Friday, February 10, 2012

FDA Issues Warning About Zocor

(HealthScout) UPDATED 2010-03-19
The U.S. Food and Drug Administration (FDA) has issued a warning about the popular cholesterol drug Zocor (simvastatin), saying that people who take the highest doses of the drug may be at increased risk for muscle injuries. Muscle pain and weakness, called myopathy, is a well-known side effect of statins, but the FDA now says that people who take the 80 mg dose of Zocor face a particularly high myopathy risk.  Read full story >
See all Cholesterol News